Patrick Mccall - Net Worth and Insider Trading
Patrick Mccall Net Worth
The estimated net worth of Patrick Mccall is at least $1,908 dollars as of 2024-12-01. Patrick Mccall is the CFO of IN8bio Inc and owns about 6,263 shares of IN8bio Inc (INAB) stock worth over $1,908. Details can be seen in Patrick Mccall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Mccall has not made any transactions after 2023-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick Mccall
Patrick Mccall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick Mccall owns 1 companies in total, including IN8bio Inc (INAB) .
Click here to see the complete history of Patrick Mccall’s form 4 insider trades.
Insider Ownership Summary of Patrick Mccall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INAB | IN8bio Inc | 2023-08-25 | Chief Financial Officer |
Patrick Mccall Latest Holdings Summary
Patrick Mccall currently owns a total of 1 stock. Patrick Mccall owns 6,263 shares of IN8bio Inc (INAB) as of August 25, 2023, with a value of $1,908.
Latest Holdings of Patrick Mccall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INAB | IN8bio Inc | 2023-08-25 | 6,263 | 0.30 | 1,908 |
Holding Weightings of Patrick Mccall
Patrick Mccall Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick Mccall has made a total of 2 transactions in IN8bio Inc (INAB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 1,000 shares on August 25, 2023, which cost Patrick Mccall around $1,030.
Insider Trading History of Patrick Mccall
- 1
Patrick Mccall Trading Performance
GuruFocus tracks the stock performance after each of Patrick Mccall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick Mccall is -23.55%. GuruFocus also compares Patrick Mccall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick Mccall within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick Mccall's insider trading performs compared to the benchmark.
Performance of Patrick Mccall
Patrick Mccall Ownership Network
Patrick Mccall Owned Company Details
What does IN8bio Inc do?
Who are the key executives at IN8bio Inc?
Patrick Mccall is the Chief Financial Officer of IN8bio Inc. Other key executives at IN8bio Inc include director & President & CEO and CFO William Tai-wei Ho , director & 10 percent owner Bios Fund Ii, Lp , and director & 10 percent owner Leslie W. Kreis .
IN8bio Inc (INAB) Insider Trades Summary
Over the past 18 months, Patrick Mccall made 1 insider transaction in IN8bio Inc (INAB) with a net purchase of 1,000. Other recent insider transactions involving IN8bio Inc (INAB) include a net purchase of 23,800 shares made by William Tai-wei Ho , a net purchase of 2,500 shares made by Jeremy R. Graff ,
In summary, during the past 3 months, insiders sold 0 shares of IN8bio Inc (INAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IN8bio Inc (INAB) were sold and 27,300 shares were bought by its insiders, resulting in a net purchase of 27,300 shares.
IN8bio Inc (INAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
IN8bio Inc Insider Transactions
Patrick Mccall Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick Mccall. You might contact Patrick Mccall via mailing address: C/o In8bio, Inc., 79 Madison Avenue, New York Ny 10016.